Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sulonga-4 granules
- Development stage
- Unknown
- Lead developer
- Inner Mongolia Autonomous Region International Mongolian Medicine Hospital
- Administration
- Oral
01
Overview
Sulonga-4 granules is a traditional Mongolian medicine herbal preparation developed by the Inner Mongolia Autonomous Region International Mongolian Medicine Hospital. It is currently being evaluated in Phase II clinical trials in China for the treatment of acute infectious diarrhea, specifically targeting Mongolian medicine subtypes characterized by 'Hira predominance' and 'mixed mucus type'. As a traditional multi-ingredient herbal formulation, its therapeutic profile is based on Mongolian medicinal principles, likely involving a combination of anti-inflammatory and gastrointestinal regulatory effects to manage symptoms of acute infection.
Beyond the preview
Go deeper on Sulonga-4 granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sulonga-4 granules.